Niki BioSolutions NIKI
NASDAQ NIKI
$4.74 -0.07 (-1.46%)
As of: Oct 2, 2026 · 11:06 AM EDT

Niki BioSolutions (NIKI) Income from Continuing Operations (2024 - 2025)

Updated

Niki BioSolutions (NIKI) reported Income from Continuing Operations of -$863,620 for FY2025.

Analysis

Niki BioSolutions (NIKI) Income from Continuing Operations (2024 - 2025) Analysis & Trends

Dating back to FY2022, Niki BioSolutions' Income from Continuing Operations record includes 4 years.

  • The FY2025 figure ranks as the highest annual Income from Continuing Operations since FY2022.
  • According to Business Quant data, Income from Continuing Operations came in at -$4.16 million in FY2024, -$4.34 million in FY2023 and $18.74 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 5.53 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 3.62 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -1.34 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 5.28 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 3.09 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 2.38 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -10.50 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -246.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.10 Bn
10 Niki BioSolutions 2.67 Mn 2.67 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2025 -283,700.00
Nov 30, 2024 -106,257.00
Aug 31, 2024 -176,275.00
API Access

Niki BioSolutions Income from Continuing Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=NIKI&period=max&api_key=YOUR_API_KEY